Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Grant/Award of 380 CADL shares, $3.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 380 | $3.3K |
| Jul 1, 2026 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 381 | $3.3K |
| Jun 24, 2026 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 32,000 | n/a |
| Apr 2, 2026 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 779 | $3.2K |
| Jun 26, 2025 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 2,141 | $10.0K |
| Jun 18, 2025 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 14,240 | n/a |
| Jun 27, 2024 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 14,240 | n/a |
| Jun 9, 2023 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 28,480 | n/a |